TAM
Tocqueville Asset Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.8M | Sell |
46,757
-143
| -0.3% | -$5.49K | 0.03% | 295 |
|
2025
Q1 | $1.82M | Hold |
46,900
| – | – | 0.03% | 278 |
|
2024
Q4 | $1.59M | Buy |
46,900
+8,950
| +24% | +$303K | 0.02% | 307 |
|
2024
Q3 | $1.55M | Hold |
37,950
| – | – | 0.02% | 297 |
|
2024
Q2 | $1.46M | Hold |
37,950
| – | – | 0.02% | 301 |
|
2024
Q1 | $1.63M | Sell |
37,950
-3,700
| -9% | -$159K | 0.03% | 296 |
|
2023
Q4 | $1.54M | Sell |
41,650
-9,150
| -18% | -$339K | 0.03% | 288 |
|
2023
Q3 | $1.84M | Buy |
50,800
+23,700
| +87% | +$859K | 0.04% | 261 |
|
2023
Q2 | $966K | Buy |
+27,100
| New | +$966K | 0.02% | 348 |
|
2017
Q3 | – | Sell |
-10,320
| Closed | -$556K | – | 822 |
|
2017
Q2 | $556K | Sell |
10,320
-1,215
| -11% | -$65.5K | 0.01% | 579 |
|
2017
Q1 | $608K | Sell |
11,535
-1,250
| -10% | -$65.9K | 0.01% | 552 |
|
2016
Q4 | $615K | Sell |
12,785
-337,164
| -96% | -$16.2M | 0.01% | 562 |
|
2016
Q3 | $18.9M | Buy |
349,949
+12,528
| +4% | +$675K | 0.23% | 117 |
|
2016
Q2 | $18.3M | Buy |
337,421
+23,107
| +7% | +$1.25M | 0.22% | 112 |
|
2016
Q1 | $15.9M | Buy |
314,314
+20,426
| +7% | +$1.04M | 0.21% | 129 |
|
2015
Q4 | $14.8M | Buy |
293,888
+11,774
| +4% | +$594K | 0.2% | 139 |
|
2015
Q3 | $13.6M | Buy |
282,114
+271,230
| +2,492% | +$13M | 0.18% | 159 |
|
2015
Q2 | $567K | Sell |
10,884
-204
| -2% | -$10.6K | 0.01% | 683 |
|
2015
Q1 | $640K | Buy |
11,088
+410
| +4% | +$23.7K | 0.01% | 662 |
|
2014
Q4 | $570K | Sell |
10,678
-788
| -7% | -$42.1K | 0.01% | 680 |
|
2014
Q3 | $659K | Sell |
11,466
-22,452
| -66% | -$1.29M | 0.01% | 567 |
|
2014
Q2 | $2.27M | Buy |
+33,918
| New | +$2.27M | 0.02% | 462 |
|
2013
Q4 | – | Sell |
-19,900
| Closed | -$1.25M | – | 1381 |
|
2013
Q3 | $1.25M | Sell |
19,900
-400
| -2% | -$25.1K | 0.02% | 488 |
|
2013
Q2 | $1.27M | Buy |
+20,300
| New | +$1.27M | 0.02% | 469 |
|